IP Australia puts kibosh on extension for Bayer’s contraceptive patent

Intellectual Property 2022-02-08 10:56 pm By Cat Fredenburgh | Melbourne

IP Australia has quashed an extension for a patent covering a Bayer oral contraceptive, saying the extension should have been calculated based on a drug that was included on the Australian Register of Therapeutic Goods at an earlier date.